Produkty 1291094-73-9

CAS 1291094-73-9 występuje w naszej ofercie pod nazwami: (1S)-1,5-Anhydro-1-C-(3-((2,3-dihydro-1,4-benzodioxin-6-yl)methyl)-4-ethylphenyl)-D-glucitol, Licogliflozin (LIK066), Licogliflozin, 98%, 98%, Licogliflozin, 98.03%. Oferty producentów: TRC, GLPBio, Chemat, MedChemExpress. Dostępne opakowania: 250mg, 1mg, 10mg, 100mg, 10mM (in 1ml dmso), 25mg, 5mg, 50mg.

(1S)-1,5-Anhydro-1-C-(3-((2,3-dihydro-1,4-benzodioxin-6-yl)methyl)-4-ethylphenyl)-D-glucitol
TRC
  • opakowanie: 250mg
  • Warianty: 1
Zobacz produkt
Licogliflozin (LIK066)
GLPBio
  • opakowanie: 1mg, 10mg, 100mg, 10mM (in 1ml dmso)
  • Warianty: 7
od 849,79
Zobacz produkt
Licogliflozin, 98%, 98%
Chemat
  • opakowanie: 1mg, 5mg, 25mg
  • Warianty: 3
od 510,80
Zobacz produkt
Licogliflozin, 98.03%
MedChemExpress
  • opakowanie: 25 mg, 10mM/1mL, 1 mg, 50 mg
  • Warianty: 7
od 505,45
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(2S,3R,4R,5S,6R)-2-[3-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-4-ethylphenyl]-6-(hydroxymethyl)oxane-3,4,5-triol (CAS 1291094-73-9) to związek chemiczny o wzorze sumarycznym C23H28O7 i masie molowej 416.5 g/mol. Nazwa systematyczna IUPAC: (2S,3R,4R,5S,6R)-2-[3-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-4-ethylphenyl]-6-(hydroxymethyl)oxane-3,4,5-triol. InChIKey: XFJAMQQAAMJFGB-ZQGJOIPISA-N.

Dane identyfikacyjne
Wzór sumarycznyC23H28O7
Masa molowa416.5 g/mol
Nazwa IUPAC(2S,3R,4R,5S,6R)-2-[3-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-4-ethylphenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
InChIKeyXFJAMQQAAMJFGB-ZQGJOIPISA-N
SMILESCCC1=C(C=C(C=C1)[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)CC3=CC4=C(C=C3)OCCO4

Dane obliczone przez PubChem (NCBI)

Synonimy: Licogliflozin, licogliflozina, licogliflozine, licogliflozinum, Licogliflozin [INN], rel-Licogliflozin, LICOGLIFLOZIN [WHO-DD], orb1707069, XFJAMQQAAMJFGB-ZQGJOIPISA-N, example 62 [WO2011048112A1]
Izomery (ten sam wzór sumaryczny)
[2-[(8S,9S,10R,13S,14S,16R,17S)-16,17-dihydroxy-10,13-dimethyl-3,11-dioxo-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate C23H28O7
[2-oxo-2-[(8R,9S,10R,11S,13S,16R,17S)-11,16,17-trihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,16-hexahydro-6H-cyclopenta[a]phenanthren-17-yl]ethyl] acetate C23H28O7
(2R,3S,4R,5R,6S)-2-(hydroxymethyl)-6-[3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]oxane-3,4,5-triol C23H28O7
[2-[(1S,2S,10S,11S,13R,14S,15S,17S)-13,14-dihydroxy-2,15-dimethyl-5-oxo-18-oxapentacyclo[8.8.0.01,17.02,7.011,15]octadeca-3,6-dien-14-yl]-2-oxoethyl] acetate C23H28O7
(8R,9S,10S)-3,4,5,19-tetramethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.02,7.014,18]nonadeca-1(19),2,4,6,12,14(18)-hexaen-8-ol C23H28O7
3-(3,4-dimethoxyphenyl)-6-(3,4,5-trimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan C23H28O7
(3S,3aR,6R,6aR)-3-(3,4-dimethoxyphenyl)-6-(3,4,5-trimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan C23H28O7
(8S,9S,10S)-3,4,5,19-tetramethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.02,7.014,18]nonadeca-1(19),2,4,6,12,14(18)-hexaen-8-ol C23H28O7